GPR35 是一种孤儿 G 蛋白偶联受体 (GPCR),在胃肠道 (GI) 中高度表达,主要在结肠上皮细胞 (CEC) 中。犬尿酸是 L-色氨酸的代谢物,被认为是 GPR3535 的内源性配体。在犬尿酸介导的 GPR35 激活后,β-arrestin 2 转移到细胞膜上以介导 GPR35 内化,导致受体脱敏。GPR35 的单核苷酸多态性已将此受体与炎症性肠病和原发性硬化性胆管炎联系起来,表明其在胃肠道炎症中发挥作用。此外,结合先前的研究结果,将 GPR35 的激动作用与伤害性疼痛的显著减少联系起来,GPR35 已成为调节 Ret 酪氨酸激酶的机械敏感性和镇痛的潜在效应物,并且是参与传递阿司匹林抗炎作用的受体——可能通过影响白细胞滚动、粘附和渗出。
GPR35 is an orphan G protein-coupled receptor (GPCR) that is highly expressed in the gastrointestinal (GI) tract, predominantly in colon epithelial cells (CEC). Kynurenic acid, a metabolite of L-tryptophan, has been proposed to be the endogenous ligand of GPR3535. Upon kynurenic acid-mediated GPR35 activation, β-arrestin 2 translocates to the cell membrane to mediate GPR35 internalization, resulting in receptor desensitization. Single nucleotide polymorphisms of GPR35 have linked this receptor to inflammatory bowel disease and primary sclerosing cholangitis, suggesting a role in gastrointestinal inflammation. In addition, in conjunction with previous findings that link agonism of GPR35 with significant reduction in nociceptive pain, GPR35 has emerged as a potential effector of regulation of mechanical sensitivity and analgesia of the Ret tyrosine kinase, and as a receptor involved in the transmission of anti-inflammatory effects of aspirin– potentially through affecting leukocyte rolling, adhesion and extravasation.
DHICA (5,6-Dihydroxyindole-2-carboxylic acid) 是一种 Eumelanin 分子砌块、GPR35 激动剂和 Melanin (MS-F41224) 合成中间体,可激活 GPR35 从而引发动态质量重分布和 β-抑制蛋白转位,可与 DNA 相互作用并干扰 Fpg 活性,促进质粒 DNA 产生单链断裂,提高 SOD 和过氧化氢酶的活性与表达水平,可用于皮肤癌和结肠癌的相关研究。
DHICA (Standard) 是 DHICA (MS-T36631) 的分析标准品,本产品用于研究及分析应用,DHICA (5,6-Dihydroxyindole-2-carboxylic acid) 是一种 Eumelanin 分子砌块、GPR35 激动剂和 Melanin (MS-F41224) 合成中间体,可激活 GPR35 引发动态质量重分布和 β-抑制蛋白转位,可与 DNA 相互作用并干扰 Fpg 活性,促进质粒 DNA 产生单链断裂,提高 SOD 和过氧化氢酶的活性与表达水平,可用于皮肤癌和结肠癌的相关研究。
GPR35 activator-1(实施例5)是一种有效的GPR35激活剂,其对人类GPR35的Ki为0.08 nM。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号